The European Scientific foundation for Laboratory Hemato Oncology (ESLHO) is a scientifically independent foundation that promotes innovation, standardization, quality control and education of laboratory diagnostics focused on lymphoid malignancies, together with the associated consortia EuroClonality, EuroFlow and EuroMRD.Read more about ESLHO
10th ESLHO Symposium (11-12 November 2021)
The 10th ESLHO Symposium on Monitoring of immunotherapies: Basis for Companion Diagnostics? will take place in Leiden, the Netherlands on 11-12 November 2021. The symposium will start with a half-day session on the IVDR, providing the latest updates on the implementation of this new Regulation.Read more about the ESLHO Symposium
EU Regulation on in vitro diagnostic medical devices (IVDR)
The IVDR, which will regulate all in vitro diagnostic medical devices (IVDs) from May 2022 onwards, will have a major impact on IVD manufacturers as well as diagnostic laboratories. To aid laboratories from the ESLHO networks with their preparations for the IVDR, including compliance to the IVDR requirements for in-house devices, ESLHO provides information and support in the form of lectures, symposia, publications and a dedicated web page.
ESLHO is a Scientific Working Group of the European Hematology Association. At the annual EHA Congress, ESLHO presents its innovations in the special EHA-SWG sessions.Read more about ESLHO’s EHA-SWG activities
IVDR Workshop videos available online
Lectures from the IVDR Workshop of the 10th ESLHO Symposium (11-12 Nov 2021) are now publicly available.
New IVDR publication on amended transition timelines and innovation
Published by the BioMed Alliance, incl. EHA.
New ESLHO website including IVDR page for diagnostic labs
The new ESLHO website is now online. It includes a web page with information on Regulation (EU) 2017/746 on in vitro diagnostic medical devices (the IVDR) and the possibility to submit questions on this topic - focused on diagnostic laboratories and in-house devices.